• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Financial Officer Kiessling Heather was granted 400,000 shares, increasing direct ownership by 97% to 812,500 units (SEC Form 4)

    4/15/25 8:42:35 AM ET
    $ASPI
    Major Chemicals
    Industrials
    Get the next $ASPI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Kiessling Heather

    (Last) (First) (Middle)
    C/O ASP ISOTOPES INC.
    601 PENNSYLVANIA AVENUE NW, SUITE 900

    (Street)
    WASHINGTON DC 20004

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ASP Isotopes Inc. [ ASPI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Financial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    04/14/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/14/2025(1) A 400,000 A (1) 812,500 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. This award of common stock shall vest (subject to compliance with applicable vesting conditions) in semi-annual installments over a four-year period beginning on the grant date.
    Remarks:
    /s/ Donald Ainscow, as attorney-in-fact 04/15/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ASPI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASPI

    DatePrice TargetRatingAnalyst
    10/4/2024$4.50Buy
    Canaccord Genuity
    12/5/2023$3.25Buy
    H.C. Wainwright
    More analyst ratings

    $ASPI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Ainscow Robert sold $1,121,347 worth of shares (200,000 units at $5.61), decreasing direct ownership by 12% to 1,419,992 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      4/17/25 7:57:41 PM ET
      $ASPI
      Major Chemicals
      Industrials
    • Chief Executive Officer Mann Paul Elliot sold $5,326,397 worth of shares (950,000 units at $5.61), decreasing direct ownership by 11% to 7,315,454 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      4/17/25 7:57:18 PM ET
      $ASPI
      Major Chemicals
      Industrials
    • Chief Operating Officer Ainscow Robert was granted 400,000 shares, increasing direct ownership by 33% to 1,619,992 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      4/15/25 8:42:42 AM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canaccord Genuity initiated coverage on ASP Isotopes with a new price target

      Canaccord Genuity initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $4.50

      10/4/24 7:13:36 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • H.C. Wainwright initiated coverage on ASP Isotopes with a new price target

      H.C. Wainwright initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $3.25

      12/5/23 7:36:42 AM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Ainscow Robert bought 19,992 shares, increasing direct ownership by 2% to 919,992 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      7/15/24 10:33:49 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • Chief Executive Officer Mann Paul Elliot bought 39,984 shares, increasing direct ownership by 0.69% to 5,845,627 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      7/15/24 10:33:33 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • Large owner Ak Jensen Investment Management Ltd bought $515,088 worth of shares (161,849 units at $3.18) (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      7/10/24 5:59:47 PM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Renergen's Phase 2 EPC Contractor Awarded Preferred Bidder Status

      JOHANNESBURG, June 18, 2025 (GLOBE NEWSWIRE) -- Renergen is pleased to announce that preferred bidder status has been awarded to He4u consortium for the design, procurement, delivery, construction and commissioning for phase 2 of the Tetra4 LNG and helium liquefaction project, comprising of, Chart Industries Inc. (NYSE:GTLS), Wilson Bayly Holmes - Ovcon Ltd (JSE: WBO), and Aurex Constructors. The appointment of an acceptable EPC contractor in Phase 2 was one of the two remaining conditions for the DFC Phase 2 loan. The award is a key milestone in the project's progress. The award confirms that Chart Industries' Helium liquefier and LNG liquefaction technologies have been selected as Tet

      6/18/25 10:11:04 AM ET
      $ASPI
      $GTLS
      Major Chemicals
      Industrials
      Metal Fabrications
    • Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream

      MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 83rd Emerging Growth Conference on June 17 & 18, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 – Presenting today, June 17, 2025 8:45Virtual Lobby opens.Register for the Conference. If you already registered, go

      6/17/25 7:00:00 AM ET
      $AEMD
      $ASPI
      $COE
      $JAGX
      Medical/Dental Instruments
      Health Care
      Major Chemicals
      Industrials
    • Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream

      MIAMI, June 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 83rd Emerging Growth Conference on June 17 & 18, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1June 17, 2025 8:45Virtual Lobby opens.Register for the Conference. If you already registered, go back to the regist

      6/16/25 7:00:00 AM ET
      $AEMD
      $ASPI
      $COE
      $JAGX
      Medical/Dental Instruments
      Health Care
      Major Chemicals
      Industrials

    $ASPI
    SEC Filings

    See more
    • ASP Isotopes Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - ASP Isotopes Inc. (0001921865) (Filer)

      6/11/25 8:48:50 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • ASP Isotopes Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - ASP Isotopes Inc. (0001921865) (Filer)

      6/4/25 10:27:08 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • SEC Form 424B5 filed by ASP Isotopes Inc.

      424B5 - ASP Isotopes Inc. (0001921865) (Filer)

      6/2/25 5:00:26 PM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Leadership Updates

    Live Leadership Updates

    See more
    • Renergen's Phase 2 EPC Contractor Awarded Preferred Bidder Status

      JOHANNESBURG, June 18, 2025 (GLOBE NEWSWIRE) -- Renergen is pleased to announce that preferred bidder status has been awarded to He4u consortium for the design, procurement, delivery, construction and commissioning for phase 2 of the Tetra4 LNG and helium liquefaction project, comprising of, Chart Industries Inc. (NYSE:GTLS), Wilson Bayly Holmes - Ovcon Ltd (JSE: WBO), and Aurex Constructors. The appointment of an acceptable EPC contractor in Phase 2 was one of the two remaining conditions for the DFC Phase 2 loan. The award is a key milestone in the project's progress. The award confirms that Chart Industries' Helium liquefier and LNG liquefaction technologies have been selected as Tet

      6/18/25 10:11:04 AM ET
      $ASPI
      $GTLS
      Major Chemicals
      Industrials
      Metal Fabrications
    • ASP Isotopes Inc. Enhances the Quantum Leap Energy LLC (QLE) Executive Leadership Team with the Appointment of Ryno Pretorius as Chief Executive Officer of QLE

      WASHINGTON , June 11, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Dr. Ryno Pretorius, PhD as Chief Executive Officer of Quantum Leap Energy LLC (QLE), the Company's subsidiary that is pursuing an initiative to develop and commercialize advanced nuclear fuels, such as High Assay Low-Enriched Uranium (HALEU) and Lithium-6. Dr. Pretorius has previously served as a consultant to both ASP Isotopes and QLE. Paul Mann will continue to serve as the chairman and C

      6/11/25 8:23:05 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • ASP Isotopes Inc. Enhances Executive Leadership Team with the Appointment of Heather Kiessling as Chief Financial Officer

      WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Heather Kiessling as its chief financial officer (CFO), effective as of July 1, 2024 (or such earlier date as may be mutually agreed), to support the Company's next pivotal phase of growth. Robert Ainscow, who currently serves as the Company's CFO and chief operating officer (COO), will continue to serve as the Company's COO, enabling him to focus his full time and attention on the Company's operat

      6/13/24 10:56:52 AM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Financials

    Live finance-specific insights

    See more
    • Mobilicom and ASP Isotopes Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / September 13, 2024 / RedChip Companies will air interviews with Mobilicom Ltd. (NASDAQ:MOB) and ASP Isotopes Inc. (NASDAQ:ASPI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, September 14, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Mobilicom: https://www.redchip.com/assets/access/mob_accessASP Isotopes: https://www.redchip.com/assets/access/aspi_accessOren Elkayam, Founder and CEO of Mobilicom, appears on the RedChip Small Stocks, Big Money™ show on Bloomberg TV to provide a corporate update. Mobilicom presents a

      9/13/24 9:00:00 AM ET
      $ASPI
      $BOXL
      $MOB
      Major Chemicals
      Industrials
      Other Consumer Services
      Real Estate
    • ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / May 24, 2024 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and Calidi Biotherapeutics Inc. (NYSE:CLDI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, May 25, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:ASP Isotopes: https://www.redchip.com/assets/access/aspi_accessCalidi Biotherapeutics: https://www.redchip.com/assets/access/cldi_accessIn an exclusive interview, Paul Mann, CEO of ASP Isotopes, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate u

      5/24/24 9:00:00 AM ET
      $ASPI
      $CLDI
      Major Chemicals
      Industrials
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • INNO Holdings and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / January 19, 2024 / RedChip Companies will air interviews with INNO Holdings, Inc. (NASDAQ:INHD) and ASP Isotopes, Inc. (NASDAQ:ASPI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, January 20, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:INNO Holdings: https://www.redchip.com/assets/access/inhd_accessASP Isotopes: https://www.redchip.com/assets/access/aspi_accessIn an exclusive interview, Alice Gong, COO of INNO Holdings, appears on the RedChip Small Stocks Big Money® Show on Bloomberg TV to provide a corporate update

      1/19/24 1:10:00 PM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by ASP Isotopes Inc.

      SC 13G - ASP Isotopes Inc. (0001921865) (Subject)

      11/14/24 3:01:19 PM ET
      $ASPI
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by ASP Isotopes Inc.

      SC 13G/A - ASP Isotopes Inc. (0001921865) (Subject)

      11/7/24 4:15:14 PM ET
      $ASPI
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by ASP Isotopes Inc.

      SC 13G - ASP Isotopes Inc. (0001921865) (Subject)

      11/3/23 4:15:20 PM ET
      $ASPI
      Major Chemicals
      Industrials